The Scientist

» opinion, immunology and disease/medicine

Most Recent

image: How Immune Receptors Got into Mouse Noses

How Immune Receptors Got into Mouse Noses

By | September 1, 2017

A study traces proteins’ evolution from the immune to the olfactory system.

0 Comments

image: Opinion: Understanding and Coping With Rising Publication Costs

Opinion: Understanding and Coping With Rising Publication Costs

By | September 1, 2017

As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.

0 Comments

image: Decoding the Tripping Brain

Decoding the Tripping Brain

By | September 1, 2017

Scientists are beginning to unravel the mechanisms behind the therapeutic effects of psychedelic drugs.

2 Comments

image: Do Microbes Trigger Alzheimer’s Disease?

Do Microbes Trigger Alzheimer’s Disease?

By | September 1, 2017

The once fringe idea is gaining traction among the scientific community.

6 Comments

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.

0 Comments

image: Infographic: The Brain on Psychedelics

Infographic: The Brain on Psychedelics

By | September 1, 2017

Understanding how hallucinogenic drugs affect different neural networks could shed light on their therapeutic potential.

0 Comments

The new technique helped pig tibias heal in just eight weeks.

0 Comments

image: Smoking on a Chip

Smoking on a Chip

By | September 1, 2017

A new device from the Wyss Institute at Harvard University simulates the effects of cigarette smoke on human lungs.

0 Comments

image: Opinion: The Flood Reduction Benefits of Wetlands

Opinion: The Flood Reduction Benefits of Wetlands

By and | August 31, 2017

Conservationists and the insurance industry team up to model the economic benefits of marshes during hurricanes.

3 Comments

image: Gilead to Pay Nearly $12B for CAR T-Cell Company

Gilead to Pay Nearly $12B for CAR T-Cell Company

By | August 28, 2017

The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.

0 Comments

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. How Microbes May Influence Our Behavior
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Sexual Touch Promotes Early Puberty
    Daily News Sexual Touch Promotes Early Puberty

    The brains and bodies of young female rats can be accelerated into puberty by the presence of an older male or by stimulation of the genitals.

AAAS